Abstract
(Chemical Equation Presented) The antitubercular nucleoside antibiotics 1 and 2 were recently described that inhibit the adenylate-forming enzyme MbtA and disrupt biosynthesis of the virulence-conferring siderophore known as mycobactin in Mycobacterium tuberculosis. Herein, we report efforts to refine this inhibitor scaffold by replacing the labile acylsulfamate linkage (highlighted) with the more chemically robust β-ketosulfonamide linkage of 3 and 4.
Original language | English (US) |
---|---|
Pages (from-to) | 4707-4710 |
Number of pages | 4 |
Journal | Organic Letters |
Volume | 8 |
Issue number | 21 |
DOIs | |
State | Published - Oct 12 2006 |